Considering the results shown above indicating that ACSL4 might be a novel regulator of mTOR, we further analyzed the mTOR pathway by Western blot using the same cell model used in the RPPA analysis and two additional breast cancer cell models. This evidence concerns the gene ACSL4 and breast cancer.